<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="12242" OLDID="470" TOPICS="YES">
<DATE> 1-APR-1987 15:10:52.71</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 

   F
   f2207 reute
r f BC-GENENTECH-&lt;GENE&gt;-SAYS   04-01 0044</UNKNOWN>
<TEXT> 
<TITLE>GENENTECH &lt;GENE&gt; SAYS FDA TO REVIEW TPA</TITLE>
<DATELINE>    SOUTH SAN FRANCISCO, April 1 - </DATELINE><BODY>Genentech Inc said Activase,
its tissue plasminogen activator, will be reviewed at the a
regularly scheduled May 29 meeting of the Food and Drug
Administration's cardiorenal advisory committee.
 Reuter
 </BODY></TEXT>
</REUTERS>